Group 1A: HER2+ Breast Cancer; Symptoms & Survivorship
Wednesday, June 14
10:00 am – 11:30 am Eastern Time (US/New York)
Mentor: Joan Mancuso
Joan Mancuso has been living with metastatic breast cancer since 2007. She was diagnosed with early stage breast cancer in 2003. For over a decade Joan has been involved in many breast cancer projects. She was an advocate member of the Translational Breast Cancer Research Consortium with Abramson Cancer Center, University of Pennsylvania. The TBCRC conducts high-impact clinical trials. Joan was also a member of the planning committee for the Metastatic Breast Cancer Research Conference’s annual meeting, working to develop the meeting’s advocate program. Through SHARE Cancer Support Joan was interviewed on talk radio to raise awareness of MBC during Breast Cancer Awareness Month. She facilitated a SHARE telephone support group for people living with MBC and wrote news stories about cancer conference sessions for an MBC newsletter, among many other projects over the years. Joan also participated as an advocate in the AACR’s Scientist<->Survivor Program. Joan is currently a volunteer in ASCO’s TAPUR Publications Group. She contributed to the section on patient education and access to the 2023 ASCO update on the use of biosimilars in oncology, published in JCO Oncology Practice. Joan was a consumer reviewer for the DOD Breast Cancer Research Program for several years and an advocate on scientific grant proposals and clinical trial protocols at major cancer centers. She is a former special reports editor on a news desk for financial news.
Scientist: Jenni Sheng, M.D.
Dr. Jenni Sheng is an Assistant Professor in the Department of Oncology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include internal medicine and oncology. Caring for men and women with cancer, she addresses living with, through and beyond cancer. As she primarily treat patients with breast cancer, she discusses the best treatment options, manages symptoms from the cancer and treatment-related side effects and focuses on psychosocial aspects of care. In keeping with comprehensive survivorship care, she plans surveillance and screening and encourages health promotion (diet, exercise and interpersonal relationships) and care coordination.